Maple syrup urine disease
Classic MSUD symptoms can present within 48 hours following birth and include sweet-smelling urine that resembles maple syrup, poor feeding, irritability, vomiting, lethargy, dystonia, and apnea. Without treatment, the disease can cause neurologic damage or death following central respiratory failure. Treatment during acute episodes of metabolic crisis is aggressive and supportive. Long-term management involves limiting the consumption of branched-chain amino acids (BCAAs) and lifelong dietary restrictions. Prognosis can be normal with early intervention and prompt treatment of episodes.
Intermittent MSUD, the second most common subtype, does not present in infancy. Patients have normal intellectual development and growth and only experience symptoms in childhood and beyond following any catabolic stress such as infection, fever, dehydration, surgery, etc. The presentation of intermittent MSUD following catabolic stress includes ketoacidosis, anorexia, nausea, vomiting, fatigue, and signs of neurotoxicity including ataxia, cognitive impairment, hallucinations, sleep disturbance, dystonia, and seizures or coma. Treatment and management are similar to classic MSUD treatment and involve prompt and aggressive intervention during acute episodes and long-term dietary restriction of BCAAs.
For more information, see OMIM.
E71.0 – Maple-syrup-urine disease
27718001 – Maple syrup urine disease
- Ketotic hypoglycemia
- Hypoxic ischemic encephalopathy
- Sepsis (see bacterial sepsis, neonatal bacterial sepsis)
- Urea cycle disorders:
- Ornithine transcarbamylase (OTC) deficiency
- Carbamoyl phosphate synthetase (CPS) deficiency
- Argininosuccinate synthetase deficiency (citrullinemia)
- Argininosuccinate lyase (ASL) deficiency
- Arginase deficiency (argininemia)
- N-acetylglutamate synthetase (NAGS) deficiency
- Propionic acidemia
- Methylmalonic acidemia